Article Text

PDF
Simultaneous analysis of the nasal shedding kinetics of field and vaccine strains of Bordetella bronchiseptica
  1. R. Iemura, MS1,
  2. R. Tsukatani1,
  3. M. J. Micallef, PhD1 and
  4. A. Taneno, DVM1
  1. 1Intervet K. K. Central Research Laboratories, 1103 Fukaya, Kasumigaura-shi, Ibaraki 300-0134, Japan
  1. E-mail for correspondence: ryuji.iemura{at}sp.intervet.com

Abstract

Groups of four two-week-old puppies were administered serial dilutions of an intranasal vaccine containing live Bordetella bronchiseptica and canine parainfluenza virus vaccine and housed individually in isolator cages. Three vaccinated groups and one unvaccinated control group were exposed to virulent B bronchiseptica four weeks after vaccination and evaluated. Nasal swabs for bacterial culture and sera for agglutination tests were taken from all the dogs every week for four weeks. The bacteria isolated were identified by growth on specific agar and by specific PCR to distinguish between vaccine and challenge strains. The vaccine strain persisted in the nasal cavity after vaccination but no adverse reactions were observed. Serum agglutination titres were raised in the vaccinated dogs at challenge. Vaccine strains were not isolated after the challenge from most of the vaccinated dogs. The challenge strain was shed in the dogs vaccinated with the lowest dose (106·0 cfu/dose) for two to three weeks but the other vaccinated groups (107·0 and 108·0 cfu/dose) shed the challenge strain transiently or not at all. Only the group vaccinated with 106·0 cfu/dose exhibited clinical signs after challenge.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.